Maitreya Medicare Valuation

Is MAITREYA undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of MAITREYA when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate MAITREYA's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate MAITREYA's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for MAITREYA?

Key metric: As MAITREYA is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for MAITREYA. This is calculated by dividing MAITREYA's market cap by their current earnings.
What is MAITREYA's PE Ratio?
PE Ratio	113.7x
Earnings	₹20.28m
Market Cap	₹2.31b

MAITREYA key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	4.8x
Enterprise Value/EBITDA	47x
PEG Ratio	n/a

Price to Earnings Ratio vs Peers

How does MAITREYA's PE Ratio compare to its peers?

The above table shows the PE ratio for MAITREYA vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	49.2x
UNIHEALTH Unihealth Hospitals	20x	n/a	₹2.3b
543346 Aashka Hospitals	71.7x	n/a	₹2.5b
543943 Asarfi Hospital	25.5x	n/a	₹1.6b
NEPHROCARE Nephro Care India	79.5x	n/a	₹3.5b
MAITREYA Maitreya Medicare	113.7x	n/a	₹2.3b

Price-To-Earnings vs Peers: MAITREYA is expensive based on its Price-To-Earnings Ratio (113.7x) compared to the peer average (49.2x).

Price to Earnings Ratio vs Industry

How does MAITREYA's PE Ratio compare vs other companies in the IN Healthcare Industry?

1 Company	Price / Earnings	Estimated Growth	Market Cap
523696 Fortis Malar Hospitals	2.1x	n/a	US$11.76m

No more companies available in this PE range

1 Company		Estimated Growth	Market Cap

No more companies

Price-To-Earnings vs Industry: MAITREYA is expensive based on its Price-To-Earnings Ratio (113.7x) compared to the Indian Healthcare industry average (41.9x).

Price to Earnings Ratio vs Fair Ratio

What is MAITREYA's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

MAITREYA PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	113.7x
Fair PE Ratio	n/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate MAITREYA's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Medico Intercontinental

₹592.5m

Trades in pharmaceutical products.

539938

₹59.25

28.6%

-37.0%

Dr Lalchandani Labs

₹78.0m

Provides diagnostic and related healthcare tests and services in India.

541299

₹18.00

n/a

N G Industries

₹547.0m

Provides various healthcare services in India.

530897

₹163.25

-2.7%

-2.5%